GraniteShares 2x Long NVDA Daily ETF vs uniQure N.V. Ordinary Shares — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $33.05 (market cap $3.52B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: GraniteShares 2x Long NVDA Daily ETF is far larger — about 2.4× uniQure N.V. Ordinary Shares's market cap, and GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long NVDA Daily ETF for 15 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NVDL | QURE | |
|---|---|---|
Market Cap | $3.52B | $1.48B |
Volume | 6,205,788 | 2,488,780 |
Sector | Leveraged / Inverse | Health |
52-Week High | $43.02 | $70.59 |
52-Week Low | $21.76 | $9.03 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $728.62M |
Signals from Pluang's Aura AI — not financial advice
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $36.58 with a 1.81% daily gain. Technical indicators show a bullish overall signal with mixed moving averages and neutral oscillators. The ETF tracks Nvidia's performance with 2x daily leverage, though recent articles highlight it underperformed NVDA's 22.21% one-year return with only 17.21%. Recent news focuses on Nvidia's strong earnings and AI leadership driving optimism.
The outlook remains tied to Nvidia's AI dominance and earnings momentum, offering leveraged exposure to chip sector growth. Key risks include leverage decay, tracking error, and Nvidia's high valuation sensitivity. Investors should weigh the ETF's daily reset mechanism against long-term holding costs amid volatile tech markets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →